AU2288992A - Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents - Google Patents
Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agentsInfo
- Publication number
- AU2288992A AU2288992A AU22889/92A AU2288992A AU2288992A AU 2288992 A AU2288992 A AU 2288992A AU 22889/92 A AU22889/92 A AU 22889/92A AU 2288992 A AU2288992 A AU 2288992A AU 2288992 A AU2288992 A AU 2288992A
- Authority
- AU
- Australia
- Prior art keywords
- amino
- therapeutic agents
- acid derivatives
- hydroxyhexanoic acid
- further novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH2689/91 | 1991-09-12 | ||
CH268991 | 1991-09-12 | ||
CH980/92 | 1992-03-27 | ||
CH98092 | 1992-03-27 | ||
CH2007/92 | 1992-06-25 | ||
CH200792 | 1992-06-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2288992A true AU2288992A (en) | 1993-03-18 |
AU661018B2 AU661018B2 (en) | 1995-07-13 |
Family
ID=27172572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU22889/92A Ceased AU661018B2 (en) | 1991-09-12 | 1992-09-10 | Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0532466A3 (en) |
JP (1) | JPH05230095A (en) |
KR (1) | KR930006050A (en) |
AU (1) | AU661018B2 (en) |
CA (1) | CA2077948A1 (en) |
CZ (1) | CZ280292A3 (en) |
FI (1) | FI924035A (en) |
HU (1) | HUT63632A (en) |
IL (1) | IL103126A (en) |
MX (1) | MX9205208A (en) |
NO (1) | NO923533L (en) |
NZ (1) | NZ244288A (en) |
PL (1) | PL169969B1 (en) |
RU (1) | RU2067585C1 (en) |
SK (1) | SK280292A3 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995007269A1 (en) * | 1993-09-10 | 1995-03-16 | Narhex Limited | Polar-substituted hydrocarbons |
US5679688A (en) * | 1992-03-11 | 1997-10-21 | Narhex Limited | Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons |
AU695516B2 (en) * | 1993-09-13 | 1998-08-13 | Abbott Laboratories | Pharmaceutical composition of HIV-protease inhibitors |
US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
US6258806B1 (en) | 1992-03-11 | 2001-07-10 | Narhex Limited | Amine derivatives of oxo- and hydroxy- substituted hydrocarbons |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643878A (en) * | 1991-09-12 | 1997-07-01 | Ciba-Geigy Corporation | 5-amino-4-hydroxyhexanoic acid derivatives |
TW217410B (en) * | 1992-04-01 | 1993-12-11 | Ciba Geigy | |
EP0604368B1 (en) | 1992-12-23 | 1996-09-18 | Ciba-Geigy Ag | Anti retroviral hydrazine derivatives |
EP0618222A3 (en) * | 1993-03-11 | 1997-01-02 | Ciba Geigy Ag | Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid. |
EP0626178A1 (en) * | 1993-05-17 | 1994-11-30 | Ciba-Geigy Ag | Use of inhibitors of HIV-protease for the treatment of tumorous diseases |
US5559158A (en) * | 1993-10-01 | 1996-09-24 | Abbott Laboratories | Pharmaceutical composition |
IL111991A (en) * | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
WO1996016980A1 (en) * | 1994-11-29 | 1996-06-06 | Novartis Ag | Morpholinoethylamide derivatives |
US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
US5840835A (en) * | 1995-10-30 | 1998-11-24 | Merck & Co., Inc. | Inhibitors of peptide binding to MHC class II proteins |
US5817757A (en) * | 1995-10-30 | 1998-10-06 | Merck & Co., Inc. | Inhibitors of peptide binding to MHO class II proteins |
AU7475396A (en) * | 1995-10-30 | 1997-05-22 | Merck & Co., Inc. | Novel inhibitors of peptide binding to mhc class ii proteins |
US5914332A (en) | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US6232333B1 (en) | 1996-11-21 | 2001-05-15 | Abbott Laboratories | Pharmaceutical composition |
HUP0105204A3 (en) * | 1999-01-28 | 2002-05-28 | Chugai Pharmaceutical Co Ltd | Substituted phenethylamine derivatives and pharmaceutical compositions containing them |
US6455734B1 (en) * | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
KR100708221B1 (en) | 1999-08-31 | 2007-04-17 | 아지노모토 가부시키가이샤 | Method for producing epoxide crystal |
DK1917958T3 (en) | 2000-01-19 | 2012-09-24 | Abbott Lab | Improved pharmaceutical formulations of HIV protease inhibitors |
US6506786B2 (en) | 2001-02-13 | 2003-01-14 | Pharmacor Inc. | HIV protease inhibitors based on amino acid derivatives |
AU2003290584B2 (en) * | 2002-11-01 | 2009-07-16 | Viropharma Incorporated | Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases |
US7388008B2 (en) | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
WO2007062526A1 (en) | 2005-11-30 | 2007-06-07 | Ambrilia Biopharma Inc. | Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
BRPI0707302B8 (en) | 2006-01-27 | 2021-05-25 | Fibrogen Inc | cyanoisoquinoline compounds that act on tissue damage associated with ischemia, hypoxia and anemia, as well as pharmaceutical composition comprising them |
RU2461557C2 (en) | 2006-04-04 | 2012-09-20 | Файброджен, Инк. | Pyrrolo- and thiazolopyridine compounds (versions) and based pharmaceutical composition |
CA2664118A1 (en) | 2006-09-21 | 2008-07-03 | Ambrilia Biopharma Inc. | Protease inhibitors |
CN102272117B (en) | 2008-11-14 | 2015-06-17 | 菲布罗根有限公司 | Thiochromene derivatives as hip hydroxylase inhibitors |
ES2694297T3 (en) | 2013-01-24 | 2018-12-19 | Fibrogen, Inc. | Crystalline forms of {[1-cyano-5- (4-chlorophenoxy) -4-hydroxy-isoquinoline-3-carbonyl] -amino} -acetic acid |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5126326A (en) * | 1989-06-06 | 1992-06-30 | Bio-Mega, Inc. | Enzyme inhibiting peptide derivatives |
-
1992
- 1992-09-03 EP EP19920810678 patent/EP0532466A3/en not_active Ceased
- 1992-09-07 JP JP4238424A patent/JPH05230095A/en active Pending
- 1992-09-09 FI FI924035A patent/FI924035A/en not_active Application Discontinuation
- 1992-09-09 KR KR1019920016530A patent/KR930006050A/en not_active Application Discontinuation
- 1992-09-10 CA CA002077948A patent/CA2077948A1/en not_active Abandoned
- 1992-09-10 NZ NZ244288A patent/NZ244288A/en unknown
- 1992-09-10 IL IL103126A patent/IL103126A/en not_active IP Right Cessation
- 1992-09-10 AU AU22889/92A patent/AU661018B2/en not_active Ceased
- 1992-09-11 NO NO92923533A patent/NO923533L/en unknown
- 1992-09-11 CZ CS922802A patent/CZ280292A3/en unknown
- 1992-09-11 PL PL92295905A patent/PL169969B1/en unknown
- 1992-09-11 MX MX9205208A patent/MX9205208A/en not_active IP Right Cessation
- 1992-09-11 HU HU9202925A patent/HUT63632A/en unknown
- 1992-09-11 SK SK2802-92A patent/SK280292A3/en unknown
- 1992-09-11 RU SU925052915A patent/RU2067585C1/en active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679688A (en) * | 1992-03-11 | 1997-10-21 | Narhex Limited | Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons |
US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
US5942504A (en) * | 1992-03-11 | 1999-08-24 | Narhex Limited | Amine derivatives of oxo- and hydroxy- substituted hydrocarbons |
US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
US6258806B1 (en) | 1992-03-11 | 2001-07-10 | Narhex Limited | Amine derivatives of oxo- and hydroxy- substituted hydrocarbons |
WO1995007269A1 (en) * | 1993-09-10 | 1995-03-16 | Narhex Limited | Polar-substituted hydrocarbons |
AU695516B2 (en) * | 1993-09-13 | 1998-08-13 | Abbott Laboratories | Pharmaceutical composition of HIV-protease inhibitors |
Also Published As
Publication number | Publication date |
---|---|
AU661018B2 (en) | 1995-07-13 |
NZ244288A (en) | 1995-03-28 |
EP0532466A3 (en) | 1993-06-16 |
SK280292A3 (en) | 1995-02-08 |
KR930006050A (en) | 1993-04-20 |
IL103126A (en) | 1997-09-30 |
PL169969B1 (en) | 1996-09-30 |
NO923533L (en) | 1993-03-15 |
MX9205208A (en) | 1993-03-01 |
NO923533D0 (en) | 1992-09-11 |
EP0532466A2 (en) | 1993-03-17 |
PL295905A1 (en) | 1993-05-17 |
JPH05230095A (en) | 1993-09-07 |
RU2067585C1 (en) | 1996-10-10 |
CZ280292A3 (en) | 1994-01-19 |
CA2077948A1 (en) | 1993-03-13 |
FI924035A0 (en) | 1992-09-09 |
FI924035A (en) | 1993-03-13 |
IL103126A0 (en) | 1993-02-21 |
HUT63632A (en) | 1993-09-28 |
HU9202925D0 (en) | 1992-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU661018B2 (en) | Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents | |
AU1803092A (en) | 7-azaisoindolinyl-quinolone- and-naphthyridonecarboxylic acid derivatives | |
AU7122291A (en) | 3-arylcarbonyl-1h-indoles useful as therapeutic agents | |
AU3105493A (en) | Quinolone- and naphthyridone-carboxylic acid derivatives | |
AU1025792A (en) | Amino acid derivatives | |
AU1739192A (en) | 7-isoindolinyl-quinolone- and -naphthyridonecarboxylic acid derivatives | |
AU616819B2 (en) | Beta-amino-boronic acid derivatives | |
AU3020595A (en) | Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments | |
IL103538A0 (en) | Quinoxaline-carboxylic and-phosphonic acid derivatives | |
AU5184193A (en) | Diaminobenzoic acid derivatives | |
AU7184994A (en) | Imidazole derivatives as therapeutic agents | |
AU1308988A (en) | Therapeutic compositions | |
AU646596B2 (en) | Substituted imidazolyl-propenoic acid derivatives | |
AU3108293A (en) | Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives | |
AU646762B2 (en) | Cyclic-substituted imidazolyl-propenoic acid derivatives | |
AU6892291A (en) | 4-hydroxyquinaldic acid derivatives | |
AU646977B2 (en) | Imidazolyl-propenoic acid derivatives | |
AU2979892A (en) | Thiazolyl-substituted quinolylmethoxphenylacetic acid derivatives | |
HU9302728D0 (en) | Pyridazinone-acetic acid derivatives | |
AU3376993A (en) | Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives | |
ZA926938B (en) | Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents | |
AU1761192A (en) | 3-amino-5-arylpyrazole-4-acetic acid derivatives exhibiting therapeutic effects | |
AU2841392A (en) | Amino acid derivatives | |
ZA93125B (en) | Quinolone- and naphthyridone-carboxylic acid derivatives | |
AU1509492A (en) | Novel thienyl-nonatetraenoic acid derivatives |